AVPT Form 4: John Ho Receives RSUs, Stake Rises to 4.3 Million Shares

Rhea-AI Filing Summary

AvePoint, Inc. (AVPT) filed a Form 4 disclosing that director John Chi On Ho received 9,744 shares of common stock in the form of restricted stock units (RSUs) on 20 June 2025 under the company’s 2021 Equity Incentive Plan. The transaction is coded “A,” indicating an acquisition rather than a disposition. The RSUs carry a grant date value that references a $17.96 share price, but no cash changed hands because the units were awarded, not bought on the open market.

Following the grant, Ho’s total beneficial ownership rose to 4,295,768 shares, reinforcing a substantial insider stake. Per the accompanying footnotes, 100% of these RSUs will vest on 1 June 2026, contingent on Ho’s continued service as a director. No derivative securities, options, or additional equity instruments were reported. The filing contains no information on company earnings, operations, or other material events; it is strictly a disclosure of insider equity compensation.

For investors, the award marginally increases insider alignment but is not large enough relative to the existing 4.3 million-share holding—or AvePoint’s overall float—to be considered materially dilutive or a strong buy signal. The absence of open-market purchases limits the direct market-sentiment read-through. Overall, the filing is routine and has limited impact on the investment thesis, though it confirms ongoing board engagement and adherence to compensation schedules.

Positive

• Director stake increases by 9,744 shares, marginally reinforcing insider alignment with shareholders.
• Total beneficial ownership now stands at approximately 4.3 million shares, demonstrating continued commitment by a board member.

Negative

• Shares were granted, not purchased, limiting the bullish signaling value typically associated with insider buying.
• Grant size is immaterial relative to the company’s share count, so dilution and market impact are negligible.

Insights

Financial Analyst

TL;DR: Routine RSU grant; minor increase in director stake, negligible market impact.

The Form 4 details a standard equity award—9,744 RSUs—to director John Chi On Ho. While any insider acquisition can be construed as a positive governance signal, this award represents roughly 0.23% of Ho’s pre-existing 4.29 million-share position and an immaterial fraction of AvePoint’s total shares outstanding. Because the shares were granted rather than purchased for cash, the behavioral signal is weaker than an open-market buy. The award vests in a single cliff on 1 June 2026, suggesting a 12-month retention horizon that modestly aligns director incentives with long-term performance. No derivative positions or dispositions were disclosed, and there are no implications for liquidity or capital structure. Bottom line: the disclosure is neutral from a valuation perspective and should not materially influence near-term trading.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ho John Chi On

(Last) (First) (Middle)

C/O JANCHOR PARTNERS LIMITED

1608 ONE EXCHANGE SQUARE

(Street)

CENTRAL, HONG KONG K3

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AvePoint, Inc. [ AVPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/20/2025		A		9,744(2)	A	$17.96	4,295,768	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This security represents the Issuer's common stock as well as restricted stock units (each, an "RSU") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.

2. 100% of the RSUs will vest on June 1, 2026, following the Reporting Person's continued service with the Issuer as of that vesting date.

	/s/ Brian Michael Brown, Attorney-in-Fact	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AvePoint (AVPT) shares did Director John Ho acquire?

He received 9,744 restricted stock units, each convertible into one share of common stock.

What is John Ho's total shareholding in AVPT after the transaction?

His beneficial ownership increased to 4,295,768 shares.

Was the transaction an open-market purchase?

No. The shares were granted as RSUs under AvePoint’s 2021 Equity Incentive Plan.

When will the newly granted RSUs vest?

100% of the RSUs vest on 1 June 2026, subject to continued service.

Does the filing mention any derivative securities or options?

No. No derivative positions were reported in Table II.